Effects of vitamin e treatment on peroxisome proliferator-activated receptor-α expression and insulin resistance in patients with non-alcoholic steatohepatitis: Results of a pilot study

Internal Medicine Journal

Volumn 37, Issue 4, 2007, Pages 229-235

  Yakaryilmaz, F ^a,e   Guliter, S ^a   Savas, B ^b   Erdem, O ^c   Ersoy, R ^d   Erden, E ^b   Akyol, G ^c   Bozkaya, H ^b   Ozenirler, S ^c  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c GAZI UNIVERSITY   (Turkey)

^d ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^e NONE   (Turkey)

Author keywords

Insulin resistance; Non alcoholic steatohepatitis; Peroxisome proliferator activated receptor ; Vitamin E

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRIACYLGLYCEROL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; LIVER FIBROSIS; LIVER FUNCTION; LIVER HISTOLOGY; METABOLIC BALANCE; NONALCOHOLIC FATTY LIVER; PILOT STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

FATTY LIVER; HUMANS; INSULIN RESISTANCE; OXIDANTS; OXIDATIVE STRESS; PILOT PROJECTS; PPAR ALPHA; VITAMIN E;

EID: 33947400987     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2006.01295.x     Document Type: Article

References (29)

1. Reid AE. Nonalcoholic steatohepatitis. Gastroenterology 2001; 121: 710-23.
2. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis and lipoprotein abnormalities: a follow up study of forty-two patients for up to 21 years. Hepatology 1990; 11: 74-80.
3. Hui JM, Farrell GC. Clear messages from sonographic shadows? Links betweenmetabolic disorders and liver disease, and what to do about them. J Gastroenterol Hepatol 2003; 18: 1115-17.
4. Choudhury J, Sanyal AJ. Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. Clin Liver Dis 2004; 8: 575-94.
5. Younossi Z, Diehl AM, Ong JP. Nonalcoholic fatty liver disease: an agenda for clinical research. Hepatology 2002; 35: 746-52.
6. Reddy JK. Nonalcoholic stetohepatitis and steatohepatitis III. Peroxisomal β-oxidation, PPAR-α and steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2001; 281: 1333-9.
7. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK et al. Nonalcoholic steaohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120: 1183-92.
8. Rao MS, Reddy JK. Peroxisomal β-oxidation and steatohepatitis. Semin Liver Dis 2001; 21: 43-55.
9. Wanless IR, Shiota K. The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis. Semin Liver Dis 2004; 24: 99-106.
10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and B-cell function from plasma fasting glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-19.
11. Alberti KG, Zimmer PZ. Definition, diagnosis and classification of diabetes mellitus and its complication. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 1998; 15: 539-53.
12. National Diabetes Data Group. Classification and diagnosis of diabetes and other categories of glucose intolerance. Diabetes 1979; 28: 1039-57.
13. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 2001; 21: 3-16.
14. Manning PJ, Sutherland WH, Walker RJ, Williams SM, De Jong SA, Ryalls AR et al. Effect of high-dose vitamin E on insulin resistance and associated parameters in overweight subjects. Diabetes Care 2004; 27: 2166-71.
15. Lavine JE. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr 2000; 136: 734-8.
16. Hasegawa T, Yoneda M, Nakamura K, Makino I, Terano A. Plasma transforming growth factor-1 level and efficacy of alpha tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. Aliment Pharmacol Ther 2001; 15: 1667-72.
17. Harrison SA, Torgerson S, Hayashi P, Ward J, Schenker S. Vitamin E and vitamin C in the treatment of nonalcoholic steatohepatitis. Am J Gastroenterol 2003; 98: 2485-90.
18. Yakaryilmaz F, Guliter S, Ozenirler S, Erdem O, Akyol G. Vitamin E treatment in patients with nonalcoholic steatohepatitis: a six-month, open-label study of sixteen patients. Curr Ther Res Clin Exp 2004; 65: 266-77.
19. Bugianesi E, Gentilcore E, Manini R, Natale S, Vanni E, Villanova N et al. A randomised controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastroenterol 2005; 100: 1082-90.
20. Sanyal AJ, Mofrad PS, Contos MJ, Sargeant C, Luketic VA, Sterling RK et al. A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 2004; 2: 1107-15.
21. Merat S, Malekzadeh R, Sohrabi MR, Hormazdi M, Naserimoghadam S, Mikaeli J et al. Probucol in the treatment of nonalcoholic steatohepatitis: an open-labeled study. J Clin Gastroenterol 2003; 36: 266-8.
22. Mehta K, Van Thiel DH, Shah N, Mobarhan S. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr Rev 2002; 60: 289-93.
23. Phung N, Farrell G, Robertson G. Vitamin E but not glutathione precursors inhibits hepatic fibrosis in experimental NASH exhibiting oxidative stress and mitochondrial abnormalities [abstract]. Hepatology 2001; 34: 361A.
24. Amarapurkar DN, Patel ND. Prevalence of metabolic syndrome in non-diabetic and non-cirrhotic patients with non-alcoholic steatohepatitis. Trop Gastroenterol 2004; 25: 125-9.
25. Tsujinaka K, Nakamura T, Maegawa H, Fujiyama M, Nishio Y, Kudo M et al. Diet high in lipid hydroperoxide by vitamin E deficiency induces insulin resistance and insulin secretion in normal rats. Diabetes Res Clin Pract 2005; 67: 99-109.
26. Vinayaga MR, Boby Z, Selvaraj N, Sridhar MG. Vitamin E protects the insulin sensitivity and redox balance in rat L6 muscle cells exposed to oxidative stress. Clin Chim Acta 2006; 367: 132-6.
27. Pessayre D, Berson A, Fromenty B, Mansouri A. Mitochondria in steatohepatitis. Semin Liver Dis 2001; 21: 57-69.
28. Ip E, Farrell GC, Robertson G, Hall P, Kirsch R, Leclercq I. Central role of PPAR alpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology 2003; 38: 123-32.
29. Sulzle A, Hirche F, Eder K. Thermally oxidized dietary fat upregulates the expression of target genes of PPAR alpha in rat liver. J Nutr 2004; 134: 1375-83.